Edition:
India

Meridian Bioscience Inc (VIVO.OQ)

VIVO.OQ on NASDAQ Stock Exchange Global Select Market

12.50USD
18 Apr 2019
Change (% chg)

$0.01 (+0.08%)
Prev Close
$12.49
Open
$12.44
Day's High
$12.55
Day's Low
$12.39
Volume
68,899
Avg. Vol
105,697
52-wk High
$19.82
52-wk Low
$12.34

Select another date:

Sat, Dec 1 2018

FDA approves Meridian Bioscience's test for herpes in newborns

The U.S. Food and Drug Administration approved on Friday the first test - a diagnostic from Meridian Bioscience Inc - to help detect a type of herpes virus in newborns.

UPDATE 1-FDA approves Meridian Bioscience's test for herpes in newborns

Nov 30 The U.S. Food and Drug Administration approved on Friday the first test - a diagnostic from Meridian Bioscience Inc - to help detect a type of herpes virus in newborns.

FDA approves Meridian Bioscience's diagnostic for herpes in newborns

Nov 30 The U.S. Food and Drug Administration approved on Friday a diagnostic test from Meridian Bioscience Inc as the first tool to help detect a type of herpes virus in newborns.

Select another date: